Tamanho, Tendências e Relatório de Crescimento de Mercado de Testes Ponto de Cuidado (POCT) da GSA e Benelux 2032

Gsa And Benelux Point Care Testing Poct Market

Tamanho do mercado em biliões de dólares

CAGR : 12.10 %

USD 3.63 Billion USD 9.07 Billion 2024 2032

Período de previsão	2025 –2032
Tamanho do mercado (ano base )	USD 3.63 Billion
Tamanho do mercado ( Ano de previsão)	USD 9.07 Billion
CAGR	12.10 %
Principais participantes do mercado	F. Hoffmann-La Roche Ltd Danaher Corporation Siemens Healthineers AG Bio-Rad Laboratories Inc. BIOMÉRIEUX

Mercado de testes no local de atendimento (POCT) da GSA e Benelux, por tipo de produto (produtos de monitoramento de glicose, produtos de teste de doenças infecciosas, produtos de monitoramento cardiometabólico, produtos de teste de gravidez e fertilidade, produtos de teste de hematologia, produtos de monitoramento de coagulação, produtos de teste de drogas de abuso (DOA), produtos de teste de urinálise, produtos de teste de colesterol, produtos de teste de marcadores tumorais/câncer, produtos de teste de ocultismo fecal e outros), por plataforma (ensaios de fluxo lateral/testes de imunocromatografia, imunoensaios, tiras reagentes, diagnóstico molecular, ensaios de química clínica, microfluídica, hematologia, outros), por aplicação (glicose no sangue, doenças infecciosas, monitoramento de sinais vitais, monitoramento cardíaco, coagulação, hematologia, monitoramento de SpO2 não invasivo, transfusão de sangue, monitoramento de PCO2 não invasivo, sangue total Análise, Outros), Por Modo de Prescrição (Testes Baseados em Prescrição e Testes de Venda Livre), Por Usuário Final (Hospitais, Assistência Domiciliar, Clínicas, Laboratórios, Centros de Diagnóstico, Laboratórios de Patologia, Centros de Cirurgia Ambulatorial, Centros de Atendimento a Idosos, Outros), Por Canal de Distribuição (Licitação Direta, Vendas no Varejo, Vendas Online e Outros) - Tendências e Previsão do Setor até 2032

Tamanho do mercado de testes no ponto de atendimento (POCT)

O tamanho do mercado de testes no ponto de atendimento (POCT) da GSA foi avaliado em US$ 3,63 bilhões em 2024 e deve atingir US$ 9,07 bilhões até 2032 , com um CAGR de 12,1% durante o período previsto.
O tamanho do mercado de testes no ponto de atendimento (POCT) do Benelux foi avaliado em US$ 882 milhões em 2024 e deve atingir US$ 1.819 milhões até 2032 , com um CAGR de 9,5% durante o período previsto.
Este crescimento é impulsionado por fatores como a crescente procura por resultados diagnósticos rápidos, o aumento da prevalência de doenças crónicas e infeciosas e os avanços nas tecnologias de diagnóstico portáteis.

Análise de mercado de testes no ponto de atendimento (POCT)

Os dispositivos de teste no ponto de atendimento (POCT) desempenham um papel vital na entrega de resultados diagnósticos rápidos no local de atendimento ao paciente ou próximo a ele, aprimorando significativamente a tomada de decisões clínicas em diversos ambientes de saúde. Esses testes são amplamente utilizados no tratamento de doenças crônicas, doenças infecciosas e atendimento de emergência.
A demanda por soluções POCT nas regiões GSA e Benelux é impulsionada principalmente pelo aumento da carga de doenças crônicas, pelo crescimento da população idosa e por um forte impulso para modelos de saúde descentralizados e centrados no paciente.
Espera-se que a Alemanha domine o mercado POCT com uma participação de 28,04% na região devido à sua infraestrutura de saúde bem estabelecida, alto rendimento diagnóstico e adoção de tecnologias médicas avançadas
Prevê-se que os países do Benelux testemunhem um forte crescimento do mercado impulsionado por iniciativas governamentais favoráveis, pelo aumento das despesas com cuidados de saúde e pela crescente adoção do POCT em ambientes clínicos e de cuidados domiciliários.
O segmento de testes de glicemia, com uma participação de 34,08%, deverá liderar o mercado de POCT na região, impulsionado pela alta prevalência de diabetes e pela demanda por ferramentas de monitoramento em tempo real que capacitem os pacientes no gerenciamento de doenças.

Escopo do relatório e segmentação do mercado de testes no ponto de atendimento (POCT)

Atributos	Principais insights do mercado de microscópios operacionais oftálmicos
Segmentos abrangidos	Por tipo de produto : produtos de monitoramento de glicose, produtos de teste de doenças infecciosas, produtos de monitoramento cardiometabólico, produtos de teste de gravidez e fertilidade, produtos de teste hematológico, produtos de monitoramento de coagulação, produtos de teste de drogas de abuso (DOA), produtos de teste de urinálise, produtos de teste de colesterol, produtos de teste de marcadores tumorais/cancerígenos, produtos de teste de ocultismo fecal e outros Por plataforma: Ensaios de fluxo lateral/testes de imunocromatografia, imunoensaios, tiras de teste, diagnóstico molecular, ensaios de química clínica, microfluídica, hematologia e outros Por aplicação: Glicose no sangue, doenças infecciosas, monitoramento de sinais vitais, monitoramento cardíaco, coagulação, hematologia, monitoramento não invasivo de SpO2, transfusão de sangue, monitoramento não invasivo de PCO2, análise de sangue total e outros Por modo de prescrição: Teste OTC, Teste baseado em prescrição Por usuário final: hospitais, atendimento domiciliar, clínicas, laboratórios, centros de diagnóstico, laboratórios de patologia, centros de cirurgia ambulatorial, centros de atendimento a idosos e outros Por canal de distribuição : licitação direta, vendas no varejo, vendas online e outros
Países abrangidos	GSA Alemanha Suíça Áustria BENELUX Bélgica Holanda Luxemburgo
Principais participantes do mercado	F. Hoffmann-La Roche Ltd (Suíça) Danaher Corporation (EUA) Siemens Healthineers AG (Alemanha) Bio-Rad Laboratories, Inc. (EUA) BIOMÉRIEUX (França) BD (EUA) QuidelOrtho Corporation (EUA) Hologic, Inc. (EUA) Thermo Fisher Scientific Inc. (EUA) Abbott (EUA) Werfen (Espanha) QIAGEN (Alemanha) Sysmex Corporation (Japão) EKF Diagnostics Holdings plc. (Reino Unido) Sekisui Diagnostics (EUA) Meridian Bioscience (EUA) binx health, inc. (EUA) Trinity Biotech (Irlanda) Sienco, Inc. (EUA) ACCUBIOTECH CO., LTD. (China)
Oportunidades de mercado	Aumento da conscientização e defesa dos testes no local de atendimento Iniciação estratégica e decisão tomada pelos participantes do mercado
Conjuntos de informações de dados de valor agregado	Além dos insights sobre cenários de mercado, como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e principais participantes, os relatórios de mercado selecionados pela Data Bridge Market Research também incluem análise de importação e exportação, visão geral da capacidade de produção, análise de consumo de produção, análise de tendência de preço, cenário de mudança climática, análise da cadeia de suprimentos, análise da cadeia de valor, visão geral de matéria-prima/consumíveis, critérios de seleção de fornecedores, análise PESTLE, análise de Porter e estrutura regulatória.

Tendências de mercado de testes no ponto de atendimento (POCT)

“Avanços em Diagnósticos Rápidos e Testes Descentralizados na GSA e no Benelux”

Uma tendência proeminente que molda o mercado POCT nas regiões GSA e Benelux é a crescente integração de conectividade digital, sensores miniaturizados e recursos de teste multiplex em dispositivos de ponto de atendimento
Essas inovações aumentam a velocidade e a precisão do diagnóstico, permitindo que os profissionais de saúde tomem decisões oportunas, especialmente em situações de emergência, gestão de doenças crônicas e triagem de doenças infecciosas.

Por exemplo, os sistemas POCT equipados com transmissão de dados sem fios e integração de registos eletrónicos de saúde (RES) são cada vez mais utilizados em contextos de cuidados primários na Alemanha e nos Países Baixos para agilizar a monitorização dos pacientes e reduzir as visitas ao hospital.

Esses avanços estão revolucionando os diagnósticos descentralizados, apoiando modelos de atendimento baseados em valor e acelerando a mudança para cuidados de saúde centrados no paciente nas regiões da GSA e Benelux.
A crescente ênfase na assistência médica preventiva, combinada com o forte apoio governamental à detecção precoce de doenças, continua a alimentar a demanda por soluções POCT de última geração com desempenho analítico e usabilidade aprimorados.

Dinâmica de mercado de testes no ponto de atendimento (POCT)

Motorista

“Uso crescente de testes POC em instalações de saúde”

O uso crescente de testes no ponto de atendimento (POC) em instalações de saúde está revolucionando a maneira como os profissionais de saúde diagnosticam e gerenciam doenças
Com a crescente necessidade de resultados diagnósticos rápidos e precisos, os profissionais de saúde estão recorrendo aos testes POC para aprimorar o atendimento aos pacientes. Essa mudança é particularmente evidente em prontos-socorros, ambulatórios e centros de diagnóstico, onde a tomada de decisões rápidas é crucial.
Os testes POC permitem que os profissionais de saúde obtenham resultados imediatos no ponto de atendimento, eliminando a necessidade de os pacientes esperarem pelos resultados laboratoriais e reduzindo significativamente o tempo de diagnóstico e tratamento.
Além disso, os testes POC são altamente portáteis e fáceis de usar, tornando-os ideais para uso em diversos ambientes de saúde, desde clínicas rurais a grandes hospitais.
A crescente prevalência de doenças crônicas e a crescente demanda por soluções de saúde eficientes impulsionam ainda mais a adoção de testes POC, pois permitem um melhor monitoramento de doenças, especialmente em condições como diabetes, doenças cardiovasculares e doenças infecciosas.
À medida que as instalações de saúde incorporam cada vez mais essas tecnologias em seus fluxos de trabalho, a demanda por testes no local de atendimento continua a crescer, atuando como um fator-chave para a expansão do mercado

Por exemplo,

Em março de 2024, segundo o NCBI, o rápido tempo de resposta do POCT aprimora a tomada de decisões clínicas, reduz o tempo de gestão e melhora a eficiência da triagem, especialmente em Departamentos de Emergência (DEs). Sua flexibilidade se estende a ambientes pré-hospitalares, hospitais de campanha e durante desastres, aglomerações ou áreas superlotadas.
Em novembro de 2024, de acordo com o artigo publicado pelo OBJECTIVE Investment Banking & Valuation, a mudança para os testes no local de atendimento (POCT) revolucionou a área da saúde, levando o diagnóstico diretamente ao local de atendimento do paciente. Sua velocidade, conveniência e eficiência o tornam inestimável em ambientes de emergência, ambulatoriais e remotos. À medida que a demanda por diagnósticos rápidos cresce,

A crescente adoção de testes no local de atendimento (POC) em unidades de saúde está transformando o diagnóstico e o tratamento de doenças. Com a necessidade de resultados rápidos e precisos, os profissionais de saúde estão utilizando os testes no local de atendimento para aprimorar o atendimento aos pacientes.

Oportunidade

“Aumento da conscientização e da defesa dos testes no local de atendimento”

À medida que os profissionais de saúde, os legisladores e o público em geral se tornam mais informados sobre os benefícios do POCT – como resultados rápidos, melhor gestão do paciente, tempos de resposta reduzidos e o potencial para testes descentralizados – há uma demanda crescente por essas soluções.
Os esforços de advocacy de grupos de pacientes, organizações profissionais e órgãos da indústria destacam ainda mais o valor do POCT em vários ambientes clínicos, incluindo departamentos de emergência, cuidados primários e até mesmo em ambientes comunitários
Este aumento de compreensão e apoio traduz-se numa maior vontade de investir e integrar o POCT nos fluxos de trabalho de saúde existentes, expandindo o tamanho e o alcance do mercado ao impulsionar uma maior adoção e utilização.

Por exemplo,

Em abril de 2023, o NCBI declarou que a esmagadora maioria dos médicos generalistas alemães (GPs), notáveis 93%, consideravam os testes no local de atendimento (POCTs) ferramentas diagnósticas valiosas em suas práticas. Eles citaram principalmente a capacidade de tomar decisões imediatas sobre o manejo do paciente e o aumento da certeza diagnóstica como os principais benefícios da utilização de POCTs.
De acordo com um artigo intitulado "Testes no local de atendimento na atenção primária na Holanda", publicado pelo Open Repository, os profissionais de saúde estão cada vez mais utilizando testes diagnósticos no local de atendimento (POC) para tomar decisões terapêuticas. O principal benefício desses testes é a capacidade de fornecer resultados rápidos diretamente no local do paciente ou próximo a ele.

Além disso, essa maior conscientização e apoio podem levar a mudanças políticas favoráveis e iniciativas de financiamento que apoiem a implementação mais ampla do POCT. Governos e sistemas de saúde na GSA e no Benelux, reconhecendo o potencial do POCT para melhorar a eficiência e o acesso a diagnósticos, podem alocar mais recursos para a adoção dessas tecnologias.
A defesa também pode influenciar os órgãos reguladores a otimizar os processos de aprovação de dispositivos POCT inovadores, acelerando sua entrada no mercado. Isso cria um ambiente mais propício ao crescimento do mercado, incentivando tanto os participantes estabelecidos quanto os novos a investir no desenvolvimento e na implantação de soluções POCT avançadas para atender à crescente demanda.

Restrição/Desafio

“Preocupações com a segurança e privacidade dos dados”

À medida que mais dispositivos POCT se integram a plataformas digitais, a coleta, a transmissão e o armazenamento de informações confidenciais de pacientes aumentam os riscos de acesso não autorizado e violações de dados. Dados de saúde, que incluem dados médicos pessoais, exigem proteção rigorosa sob leis como HIPAA e GDPR, criando complexidades adicionais de conformidade para fabricantes e provedores de saúde.
A falta de estruturas de segurança robustas e protocolos de criptografia em alguns dispositivos POCT amplifica ainda mais essas preocupações.
Além disso, a hesitação dos pacientes em compartilhar seus dados médicos devido a riscos à privacidade pode dificultar a adoção generalizada, especialmente em regiões onde a confiança em soluções de saúde digital é limitada. O desenvolvimento contínuo de sistemas seguros e em conformidade com a privacidade é crucial, mas as preocupações atuais atuam como um freio, desacelerando o ritmo de inovação e adoção no mercado POCT da GSA e do Benelux.

Por exemplo,

Em julho de 2021, de acordo com o blog publicado pelo MDPI, um aspecto relevante a ser considerado em relação aos riscos de segurança cibernética e privacidade são os sistemas de ponto de atendimento (POC) de saúde, amplamente utilizados em hospitais. Os sistemas POC são plataformas que incorporam dispositivos e aplicativos para coletar, processar e visualizar dados. Utilizando grandes quantidades de dados, que contêm informações pessoais de saúde e dados médicos sensíveis, comunicados por vários sistemas POC, plataformas analíticas de back-end, estações de trabalho de usuários e smartphones, torna-se evidente a existência de múltiplas ameaças que causam vazamentos de dados ou incidentes de violação que prejudicam a vida do paciente. Os testes de ponto de atendimento são vulneráveis a vazamentos de dados, o que atua como uma restrição ao crescimento do mercado.

Preocupações com a segurança e a privacidade dos dados são grandes desafios para o mercado de Testes Point-of-Care (POCT) da GSA e Benelux. À medida que mais dispositivos se conectam a plataformas digitais, o risco de acesso não autorizado e violações de dados aumenta, especialmente no que diz respeito a informações confidenciais de pacientes. A conformidade com regulamentações como HIPAA e GDPR aumenta a complexidade para fabricantes e provedores de saúde. A falta de segurança robusta em alguns dispositivos e as preocupações dos pacientes com a privacidade podem atrasar a adoção, especialmente em regiões com confiança limitada em soluções de saúde digital. O desenvolvimento de sistemas seguros e em conformidade com a privacidade é essencial para superar essas barreiras.

Escopo de mercado de testes no ponto de atendimento (POCT)

O mercado é segmentado com base na aplicação, tipo de produto, tecnologia, tipo de ampliação, usuário final e canal de distribuição.

Segmentação	Sub-segmentação
Por tipo de produto	Produtos de monitoramento de glicose Produtos para testes de doenças infecciosas Produtos de monitoramento cardiometabólico Produtos para testes de gravidez e fertilidade Produtos para testes de hematologia Produtos de monitoramento de coagulação Produtos para teste de drogas de abuso (DOA) Produtos para teste de urinálise Produtos para teste de colesterol Produtos para teste de marcadores tumorais/cancerígenos Produtos para teste de ocultismo fecal Outros
Por plataforma	Ensaios de fluxo lateral/testes de imunocromatografia Imunoensaios Varetas de nível Diagnóstico Molecular Ensaios de Química Clínica Microfluídica Hematologia Outros
Por aplicação	Glicose no sangue Doenças Infecciosas Monitoramento de sinais vitais Monitoramento cardíaco Coagulação Hematologia Monitoramento de SpO2 não invasivo Transfusão de sangue Monitoramento de PCO2 não invasivo Análise de Sangue Total Outros
Por modo de prescrição	Testes OTC Testes baseados em prescrição
Por usuário final	Hospitais Clínicas de Assistência Domiciliar Laboratórios Centros de Diagnóstico Laboratórios de Patologia Centros de Cirurgia Ambulatorial Centros de Cuidados para Idosos Outros
Por canal de distribuição	Licitação Direta Vendas no varejo Vendas online Outros

Em 2025, projeta-se que os produtos de monitoramento de glicose dominem o mercado com a maior participação no segmento de tipo de produto

Espera-se que o segmento de produtos de monitoramento de glicose domine o mercado de testes no local de atendimento (POCT) com a maior participação de 34,08% em 2025 devido à alta prevalência de diabetes e à necessidade frequente de testes de glicose no sangue convenientes e imediatos.

Espera-se que os ensaios de fluxo lateral/testes de imunocromatografia representem a maior fatia durante o período de previsão no segmento de plataforma

Em 2025, espera-se que o segmento de ensaios de fluxo lateral/testes de imunocromatografia domine o mercado com a maior participação de mercado de 37,28% devido à sua simplicidade, resultados rápidos, custo-efetividade e adequação para uma ampla gama de aplicações de diagnóstico fora dos ambientes laboratoriais tradicionais.

Análise regional do mercado de testes no ponto de atendimento (POCT)

“A Alemanha detém a maior fatia do mercado de testes no local de atendimento (POCT)”

A Alemanha domina o mercado de testes no ponto de atendimento (POCT) com uma participação de 82,06% , dentro da região GSA, impulsionada por uma infraestrutura de saúde altamente desenvolvida, ampla adoção de tecnologias de diagnóstico inovadoras e uma forte ênfase na medicina preventiva e personalizada.
O país detém uma participação significativa devido à crescente demanda por soluções de diagnóstico rápidas e precisas, especialmente no tratamento de doenças crônicas como diabetes, doenças cardiovasculares e infecções respiratórias.
Estruturas de reembolso de suporte, iniciativas de saúde digital apoiadas pelo governo e investimentos robustos em P&D na área da saúde impulsionam ainda mais o crescimento do mercado
Além disso, a crescente implementação do POCT em departamentos de emergência, ambientes de atenção primária e assistência médica domiciliar — juntamente com o foco na redução da carga hospitalar — está impulsionando a expansão do mercado em toda a Alemanha.

“Prevê-se que a Holanda registre o maior CAGR no mercado de testes no ponto de atendimento (POCT)”

Espera-se que a Holanda testemunhe um crescimento robusto no mercado de testes no ponto de atendimento (POCT), com uma participação de 54,40% , impulsionado por seu forte foco em saúde digital, detecção precoce de doenças e modelos de atendimento centrados no paciente.
O envelhecimento da população do país e a crescente prevalência de doenças crônicas, como diabetes, doenças cardiovasculares e respiratórias, estão alimentando a demanda por soluções de diagnóstico rápidas e descentralizadas.
Com um sistema de cuidados primários bem estabelecido e políticas de saúde progressivas, os Países Baixos continuam a ser um dos principais adotantes de tecnologias POCT, particularmente em ambientes de saúde comunitários, clínicas de médicos generalistas (GP) e serviços de assistência domiciliária.
A crescente integração dos dispositivos POCT com os registos eletrónicos de saúde (RES), o apoio das seguradoras de saúde à inovação no diagnóstico e a participação ativa em iniciativas tecnológicas de saúde em toda a UE estão a reforçar ainda mais as perspetivas de mercado
As colaborações entre instituições acadêmicas, startups de tecnologia e empresas de diagnóstico estão acelerando a inovação e o desenvolvimento local de soluções POCT avançadas e fáceis de usar, adaptadas ao sistema de saúde holandês.

Participação de mercado de testes no ponto de atendimento (POCT)

O cenário competitivo do mercado fornece detalhes por concorrente. Os detalhes incluem visão geral da empresa, finanças da empresa, receita gerada, potencial de mercado, investimento em pesquisa e desenvolvimento, novas iniciativas de mercado, presença global, locais e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa, lançamento de produto, amplitude e abrangência do produto e domínio da aplicação. Os pontos de dados fornecidos acima referem-se apenas ao foco das empresas em relação ao mercado.

Os principais líderes de mercado que operam no mercado são:

F. Hoffmann-La Roche Ltd (Suíça)
Danaher Corporation (EUA)
Siemens Healthineers AG (Alemanha)
Bio-Rad Laboratories, Inc. (EUA)
BIOMÉRIEUX (França)
BD (EUA)
QuidelOrtho Corporation (EUA)
Hologic, Inc. (EUA)
Thermo Fisher Scientific Inc. (EUA)
Abbott (EUA)
Werfen (Espanha)
QIAGEN (Alemanha)
Sysmex Corporation (Japão)
EKF Diagnostics Holdings plc. (Reino Unido)
Sekisui Diagnostics (EUA)
Meridian Bioscience (EUA)
binx health, inc. (EUA)
Trinity Biotech (Irlanda)
Sienco, Inc. (EUA)
ACCUBIOTECH CO., LTD. (China)

Últimos desenvolvimentos no mercado de testes no ponto de atendimento (POCT) da GSA e Benelux

Em dezembro de 2023, a Roche adquiriu partes selecionadas da inovadora tecnologia Point of Care da LumiraDx, aprimorando seu portfólio de diagnósticos. Essa aquisição permite testes mais rápidos e acessíveis em diversas áreas de doenças. A integração da plataforma da LumiraDx melhorará o acesso dos pacientes a resultados diagnósticos precisos e oportunos em ambientes de saúde descentralizados em todo o mundo.
Em janeiro de 2025, a Danaher Corporation firmou uma parceria de investimento com a Innovaccer Inc., uma empresa de IA para a área da saúde. Essa colaboração visa acelerar a adoção de diagnósticos de precisão e cuidados baseados em valor, fornecendo aos profissionais de saúde dados unificados de pacientes e análises avançadas, melhorando os resultados dos pacientes por meio de intervenções personalizadas e oportunas.
Em outubro de 2024, a bioMérieux apelou à colaboração multissetorial para promover a agenda global sobre resistência antimicrobiana (RAM). A empresa enfatiza a necessidade urgente de esforços conjuntos da saúde, do governo e da indústria para abordar a RAM, promovendo soluções diagnósticas inovadoras e o uso responsável de antimicrobianos para combater esta crescente ameaça global à saúde.
Em março de 2024, a Bio-Rad lançou a solução XP-Design Assay para sorotipagem de Salmonella, para testes rápidos e precisos de segurança alimentar. A solução XP-Design Assay para sorotipagem de Salmonella proporcionou uma abordagem flexível para identificar sorotipos de Salmonella após a triagem inicial. A solução pronta para uso contém oligonucleotídeos (primers e sondas) específicos para o sorotipo alvo, garantindo alta especificidade e reduzindo o risco de reação cruzada, proporcionando resultados confiáveis.

SKU-74050

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

Click on image to enlarge

Painel interativo de análise de dados
Painel de análise da empresa para oportunidades de elevado potencial de crescimento
Acesso de analista de pesquisa para personalização e customização. consultas
Análise da concorrência com painel interativo
Últimas notícias, atualizações e atualizações Análise de tendências
Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência

Pedido de demonstração

Índice

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 YEARS CONSIDERED FOR THE STUDY

2.3 CURRENCY AND PRICING

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 MULTIVARIATE MODELLING

2.6 PRODUCT TYPE LIFELINE CURVE

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 MARKET END USER COVERAGE GRID

2.1 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

4.3 MICRO AND MACRO ECONOMIC FACTORS

4.4 PENETRATION AND GROWTH PROSPECT MAPPING

4.5 KEY PRICING STRATEGIES

4.6 COST ANALYSIS BREAKDOWN

4.7 OPPORTUNITY MAP ANALYSIS

4.8 VALUE CHAIN ANALYSIS

4.9 HEALTHCARE ECONOMY

4.1 TARIFFS

4.10.1 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR

4.10.2 GLOBAL VS. REGIONAL TARIFF STRUCTURES

4.10.3 IMPACT OF TARIFFS ON HEALTHCARE COSTS AND ACCESSIBILITY

4.10.4 TARIFF REGULATIONS IN KEY MARKETS

4.10.4.1 MEDICARE/MEDICAID TARIFF POLICIES

4.10.4.2 CMS PRICING MODELS

4.10.4.3 OTHERS

4.10.5 TARIFFS ON MEDICAL DEVICES & EQUIPMENT

4.10.5.1 IMPORT/EXPORT DUTIES ON MEDICAL EQUIPMENT

4.10.5.2 IMPACT ON PRICING AND AVAILABILITY OF HIGH-END MEDICAL TECHNOLOGY

4.10.5.3 CASE STUDIES OF TARIFF CHANGES AFFECTING THE INDUSTRY

4.10.6 COST BURDEN ON HOSPITALS AND HEALTHCARE FACILITIES

4.10.7 TARIFF EXEMPTIONS AND INCENTIVES

4.10.8 DUTY-FREE IMPORTS FOR ESSENTIAL MEDICINES AND VACCINES

4.10.9 16.9 IMPACT OF TRADE WARS ON THE HEALTHCARE SUPPLY CHAIN

4.10.10 ROLE OF FREE TRADE AGREEMENTS (FTAS) IN REDUCING TARIFFS

5 CUSTOMIZATION

5.1 LEADING DIGITAL HEALTH PLATFORMS IN EACH COUNTRY –

5.2 POCT DATA INTEGRATION USE CASES –

5.3 INFORMATICS PLATFORMS & TELEMEDICINE INTEGRATION:

6 REGULATORY

6.1 REGULATORY GSA

6.2 REGULATORY BENELUX

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES

7.1.2 RISING INCIDENCE OF SUBSTANCE ABUSE

7.1.3 INCREASED ADOPTION OF TELEMEDICINE

7.1.4 ADVANCEMENTS TECHNOLOGIES ENHANCING POC TESTING WITH BIOSENSORS AND MOBILE INTEGRATION

7.2 RESTRAINTS

7.2.1 DATA SECURITY AND PRIVACY CONCERNS

7.2.2 ACCURACY LIMITATIONS AND TECHNICAL BARRIERS

7.3 OPPORTUNITIES

7.3.1 RISING AWARENESS AND ADVOCACY FOR POINT-OF-CARE TESTING

7.3.2 STRATEGIC INITIATION AND DECISION TAKEN BY THE MARKET PLAYERS

7.3.3 EXPANDING PRODUCT RANGE FOR POINT-OF-CARE TESTING

7.4 CHALLENGES

7.4.1 LIMITED AWARENESS AND ACCEPTANCE OF POINT-OF-CARE (POC) TESTING

7.4.2 IMPACT OF HIGH MAINTENANCE COSTS THREATEN POINT-OF-CARE TESTING (POCT) SUSTAINABILITY IN LOW-RESOURCE SETTINGS

8 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT TYPE

8.1 OVERVIEW

8.2 GLUCOSE MONITORING PRODUCTS

8.2.1 STRIPS

8.2.2 METERS

8.2.3 LANCETS AND LANCING DEVICES

8.3 INFECTIOUS DISEASE TESTING PRODUCTS

8.3.1 COVID-19

8.3.2 HIV TESTING PRODUCTS

8.3.2.1 TESTING REAGENTS

8.3.2.2 TESTING EQUIPMENT

8.3.3 RESPIRATORY INFECTION TESTING PRODUCTS

8.3.4 SEXUALLY TRANSMITTED DISEASES (STD) TESTING

8.3.4.1 NAAT-BASED SYSTEMS

8.3.4.2 NON–NAAT-BASED SYSTEMS

8.3.5 HEPATITIS C TESTING PRODUCTS

8.3.5.1 HCV ANTIBODY TESTS

8.3.5.2 HCV VIRAL LOAD TESTS

8.3.6 INFLUENZA TESTING PRODUCTS

8.3.6.1 TRADITIONAL DIAGNOSTIC TEST

8.3.6.1.1 RAPID INFLUENZA DIAGNOSTIC TEST (RIDT)

8.3.6.1.2 DIRECT FLUORESCENT ANTIBODY TEST (DFAT)

8.3.6.1.3 VIRAL CULTURE

8.3.6.1.4 SEROLOGICAL ASSAY

8.3.6.2 MOLECULAR DIAGNOSTIC ASSAY

8.3.6.2.1 RT-PCR

8.3.6.2.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION-BASED ASSAY (LAMP)

8.3.6.2.3 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION TEST (NASBAT)

8.3.6.2.4 SIMPLE AMPLIFICATION-BASED ASSAY (SAMBA)

8.3.7 HEALTHCARE ASSOCIATED INFECTION (HAI) TESTING

8.3.8 TROPICAL DISEASE TESTING PRODUCTS

8.3.9 OTHER INFECTIOUS DISEASE TESTING PRODUCTS

8.4 CARDIOMETABOLIC MONITORING PRODUCTS

8.4.1 CARDIAC MARKER TESTING PRODUCTS

8.4.1.1 HSTNL

8.4.1.2 BNP

8.4.1.3 D-DIMER

8.4.1.4 CK-MB

8.4.1.5 MYOGLOBIN

8.4.2 BLOOD GAS/ELECTROLYTE TESTING PRODUCTS

8.4.3 BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES

8.4.3.1 CARTRIDGES

8.4.3.2 REAGENTS

8.4.4 BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS

8.4.4.1 PORTABLE

8.4.4.1.1 COMBINED ANALYZERS

8.4.4.1.2 BLOOD GAS ANALYZERS

8.4.4.1.3 ELECTROLYTE ANALYZERS

8.4.4.2 BENCHTOP

8.4.4.2.1 COMBINED ANALYZERS

8.4.4.2.2 BLOOD GAS ANALYZERS

8.4.4.2.3 ELECTROLYTE ANALYZERS

8.4.5 HBA1C TESTING PRODUCTS

8.4.5.1 HBA1C TESTING INSTRUMENTS

8.4.5.2 HBA1C TESTING CONSUMABLES

8.4.6 POC ANALYZER

8.4.7 ECG DEVICE

8.4.7.1 RESTING ECG DEVICES

8.4.7.2 STRESS ECG DEVICES

8.4.7.3 HOLTER MONITORS

8.5 PREGNANCY AND FERTILITY TESTING PRODUCTS

8.5.1 PREGNANCY TESTING PRODUCTS

8.5.1.1 STRIPS/ DIP STICKS AND CARDS

8.5.1.2 MID STREAM DEVICES

8.5.1.3 CASSETTES

8.5.1.4 DIGITAL DEVICES

8.5.1.5 LINE-INDICATOR DEVICES

8.5.2 FERTILITY TESTING PRODUCTS

8.5.2.1 LUTEINIZING HORMONE (LH) URINE TEST

8.5.2.2 FSH TEST

8.5.2.3 OTHERS

8.6 HAEMATOLOGY TESTING PRODUCTS

8.7 COAGULATION MONITORING PRODUCTS

8.7.1 ANTICOAGULATION MONITORING DEVICES

8.7.1.1 PROTHROMBIN TIME/INTERNATIONAL NORMALIZED RATIO (PT-INR) TESTING DEVICES

8.7.1.2 ACTIVATED CLOTTING TIME (ACT)

8.7.1.3 ACTIVATED PARTIAL THROMBOPLASTIN TIME (APPT)

8.7.2 PLATELET FUNCTION MONITORING DEVICES

8.7.3 VISCOELASTIC COAGULATION MONITORING DEVICES

8.7.3.1 ROTATIONAL THROMBOELASTOMETRY (ROTEM)

8.7.3.2 THROMBOELASTOGRAPHY (TEG)

8.8 DRUG-OF-ABUSE (DOA) TESTING PRODUCTS

8.8.1 DOA ANALYSERS

8.8.1.1 IMMUNOASSAYS

8.8.1.2 CHROMATOGRAPHIC DEVICES

8.8.1.3 BREATH ANALYSERS

8.8.2 RAPID TESTING DEVICES

8.8.2.1 URINE TESTING DEVICES

8.8.2.2 ORAL FLUID TESTING DEVICES

8.8.2.3 OTHERS

8.9 URINALYSIS TESTING PRODUCTS

8.9.1 POC URINE STRIP SELF-TESTING

8.9.2 POC URINE TEST STRIP PROFESSIONAL TESTING

8.1 CHOLESTEROL TESTING PRODUCTS

8.10.1 TESTING KITS

8.10.2 INSTRUMENTS

8.10.2.1 TABLE-TOP ANALYZERS

8.10.2.2 HAND-HELD ANALYZERS

8.11 TUMOR/CANCER MARKER TESTING PRODUCTS

8.12 FECAL OCCULT TESTING PRODUCTS

8.12.1 GUAIAC FOB STOOL TEST

8.12.2 LATERAL FLOW IMMUNO-FOB TEST

8.12.3 IMMUNO-FOB AGGLUTINATION TEST

8.12.4 IMMUNO-FOB ELISA TEST

8.13 OTHERS

9 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE

9.1 OVERVIEW

9.2 OTC TESTING

9.3 PRESCRIPTION-BASED TESTING

10 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY PLATFORM

10.1 OVERVIEW

10.2 LATERAL FLOW ASSAYS/IMMUNOCHROMATOGRAPHY TESTS

10.3 IMMUNOASSAYS

10.4 DIPSTICKS

10.5 MOLECULAR DIAGNOSTICS

10.6 CLINICAL CHEMISTRY ASSAYS

10.7 MICROFLUIDICS

10.8 HEMATOLOGY

10.9 OTHERS

11 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 BLOOD GLUCOSE

11.3 INFECTIOUS DISEASES

11.3.1 COVID-19 TESTING

11.3.2 HIV TESTING

11.3.3 HEPATITIS C TESTING

11.3.4 INFLUENZA TESTING

11.3.5 TUBERCULOSIS TESTING

11.3.6 OTHERS

11.4 VITAL SIGN MONITORING

11.5 CARDIAC MONITORING

11.6 COAGULATION

11.7 HAEMATOLOGY

11.8 NON- INVASIVE SPO2 MONITORING

11.9 BLOOD TRANSFUSION

11.1 NON- INVASIVE PCO2 MONITORING

11.11 WHOLE BLOOD ANALYSIS

11.12 OTHERS

12 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS

12.2.1 PRIVATE

12.2.1.1 TIER 1

12.2.1.2 TIER 2

12.2.1.3 TIER 3

12.2.2 PUBLIC

12.3 HOME CARE

12.4 CLINICS

12.5 LABORATORIES

12.6 DIAGNOSTIC CENTERS

12.7 PATHOLOGY LABS

12.8 AMBULATORY SURGERY CENTERS

12.9 ELDERLY CARE CENTERS

12.1 OTHERS

13 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 DIRECT TENDER

13.3 RETAIL SALES

13.4 ONLINE SALES

13.5 OTHERS

14 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT TYPE

14.1 OVERVIEW

14.2 GLUCOSE MONITORING PRODUCTS

14.2.1 STRIPS

14.2.2 METERS

14.2.3 LANCETS AND LANCING DEVICES

14.3 INFECTIOUS DISEASE TESTING PRODUCTS

14.3.1 COVID-19

14.3.2 HIV TESTING PRODUCTS

14.3.2.1 TESTING REAGENTS

14.3.2.2 TESTING EQUIPMENT

14.3.3 RESPIRATORY INFECTION TESTING PRODUCTS

14.3.4 SEXUALLY TRANSMITTED DISEASES (STD) TESTING

14.3.5 NAAT-BASED SYSTEMS

14.3.6 NON–NAAT-BASED SYSTEMS

14.3.7 HEPATITIS C TESTING PRODUCTS

14.3.7.1 HCV ANTIBODY TESTS

14.3.7.2 HCV VIRAL LOAD TESTS

14.3.8 INFLUENZA TESTING PRODUCTS

14.3.8.1 TRADITIONAL DIAGNOSTIC TEST

14.3.8.1.1 RAPID INFLUENZA DIAGNOSTIC TEST (RIDT)

14.3.8.1.2 DIRECT FLUORESCENT ANTIBODY TEST (DFAT)

14.3.8.1.3 VIRAL CULTURE

14.3.8.1.4 SEROLOGICAL ASSAY

14.3.8.2 MOLECULAR DIAGNOSTIC ASSAY

14.3.8.2.1 RT-PCR

14.3.8.2.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION-BASED ASSAY (LAMP)

14.3.8.2.3 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION TEST (NASBAT)

14.3.8.2.4 SIMPLE AMPLIFICATION-BASED ASSAY (SAMBA)

14.3.9 HEALTHCARE ASSOCIATED INFECTION (HAI) TESTING

14.3.10 TROPICAL DISEASE TESTING PRODUCTS

14.3.11 OTHER INFECTIOUS DISEASE TESTING PRODUCTS

14.4 CARDIOMETABOLIC MONITORING PRODUCTS

14.4.1 CARDIAC MARKER TESTING PRODUCTS

14.4.1.1 HSTNL

14.4.1.2 BNP

14.4.1.3 D-DIMER

14.4.1.4 CK-MB

14.4.1.5 MYOGLOBIN

14.4.2 BLOOD GAS/ELECTROLYTE TESTING PRODUCTS

14.4.3 BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES

14.4.3.1 CARTRIDGES

14.4.3.2 REAGENTS

14.4.4 BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS

14.4.5 PORTABLE

14.4.5.1 COMBINED ANALYZERS

14.4.5.2 BLOOD GAS ANALYZERS

14.4.5.3 ELECTROLYTE ANALYZERS

14.4.6 BENCHTOP

14.4.6.1 COMBINED ANALYZERS

14.4.6.2 BLOOD GAS ANALYZERS

14.4.6.3 ELECTROLYTE ANALYZERS

14.4.7 HBA1C TESTING PRODUCTS

14.4.7.1 HBA1C TESTING INSTRUMENTS

14.4.7.2 HBA1C TESTING CONSUMABLES

14.4.8 POC ANALYZER

14.4.9 ECG DEVICE

14.4.9.1 RESTING ECG DEVICES

14.4.9.2 STRESS ECG DEVICES

14.4.9.3 HOLTER MONITORS

14.5 PREGNANCY AND FERTILITY TESTING PRODUCTS

14.5.1 PREGNANCY TESTING PRODUCTS

14.5.1.1 STRIPS/ DIP STICKS AND CARDS

14.5.1.2 MID STREAM DEVICES

14.5.1.3 CASSETTES

14.5.1.4 DIGITAL DEVICES

14.5.1.5 LINE-INDICATOR DEVICES

14.5.2 FERTILITY TESTING PRODUCTS

14.5.2.1 LUTEINIZING HORMONE (LH) URINE TEST

14.5.2.2 FSH TEST

14.5.2.3 OTHERS

14.6 HAEMATOLOGY TESTING PRODUCTS

14.7 COAGULATION MONITORING PRODUCTS

14.8 ANTICOAGULATION MONITORING DEVICES

14.8.1 PROTHROMBIN TIME/INTERNATIONAL NORMALIZED RATIO (PT-INR) TESTING DEVICES

14.8.2 ACTIVATED CLOTTING TIME (ACT)

14.8.3 ACTIVATED PARTIAL THROMBOPLASTIN TIME (APPT)

14.8.4 PLATELET FUNCTION MONITORING DEVICES

14.8.5 VISCOELASTIC COAGULATION MONITORING DEVICES

14.8.5.1 ROTATIONAL THROMBOELASTOMETRY (ROTEM)

14.8.5.2 THROMBOELASTOGRAPHY (TEG)

14.9 DRUG-OF-ABUSE (DOA) TESTING PRODUCTS

14.9.1 DOA ANALYSERS

14.9.1.1 IMMUNOASSAYS

14.9.1.2 CHROMATOGRAPHIC DEVICES

14.9.1.3 BREATH ANALYSERS

14.9.2 RAPID TESTING DEVICES

14.9.2.1 URINE TESTING DEVICES

14.9.2.2 ORAL FLUID TESTING DEVICES

14.9.3 OTHERS

14.1 URINALYSIS TESTING PRODUCTS

14.10.1 POC URINE STRIP SELF-TESTING

14.10.2 POC URINE TEST STRIP PROFESSIONAL TESTING

14.11 CHOLESTEROL TESTING PRODUCTS

14.11.1 TESTING KITS

14.11.2 INSTRUMENTS

14.11.2.1 TABLE-TOP ANALYZERS

14.11.2.2 HAND-HELD ANALYZERS

14.12 TUMOR/CANCER MARKER TESTING PRODUCTS

14.13 FECAL OCCULT TESTING PRODUCTS

14.13.1 GUAIAC FOB STOOL TEST

14.13.2 LATERAL FLOW IMMUNO-FOB TEST

14.13.3 IMMUNO-FOB AGGLUTINATION TEST

14.13.4 IMMUNO-FOB ELISA TEST

14.14 OTHERS

15 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY PLATFORM

15.1 OVERVIEW

15.2 LATERAL FLOW ASSAYS/IMMUNOCHROMATOGRAPHY TESTS

15.3 IMMUNOASSAYS

15.4 DIPSTICKS

15.5 MOLECULAR DIAGNOSTICS

15.6 CLINICAL CHEMISTRY ASSAYS

15.7 MICROFLUIDICS

15.8 HEMATOLOGY

15.9 OTHERS

16 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE

16.1 OVERVIEW

16.2 OTC TESTING

16.3 PRESCRIPTION-BASED TESTING

17 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION

17.1 OVERVIEW

17.2 BLOOD GLUCOSE

17.3 INFECTIOUS DISEASES

17.3.1.1 COVID-19 TESTING

17.3.1.2 HIV TESTING

17.3.1.3 HEPATITIS C TESTING

17.3.1.4 INFLUENZA TESTING

17.3.1.5 TUBERCULOSIS TESTING

17.3.1.6 OTHERS

17.4 VITAL SIGN MONITORING

17.5 CARDIAC MONITORING

17.6 COAGULATION

17.7 HAEMATOLOGY

17.8 NON- INVASIVE SPO2 MONITORING

17.9 BLOOD TRANSFUSION

17.1 NON- INVASIVE PCO2 MONITORING

17.11 WHOLE BLOOD ANALYSIS

17.12 OTHERS

18 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY END USER

18.1 OVERVIEW

18.2 HOSPITALS

18.2.1 PRIVATE

18.2.1.1 TIER 1

18.2.1.2 TIER 2

18.2.1.3 TIER 3

18.2.2 PUBLIC

18.3 HOME CARE

18.4 CLINICS

18.5 LABORATORIES

18.6 DIAGNOSTIC CENTERS

18.7 PATHOLOGY LABS

18.8 AMBULATORY SURGERY CENTERS

18.9 ELDERLY CARE CENTERS

18.1 OTHERS

19 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL

19.1 OVERVIEW

19.2 DIRECT TENDER

19.3 RETAIL SALES

19.4 ONLINE SALES

19.5 OTHERS

20 GSA & BENELUX

20.1 GERMANY

20.2 NETHERLANDS

20.3 SWITZERLAND

20.4 BELGIUM

20.5 AUSTRIA

20.6 LUXEMBOURG

21 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY LANDSCAPE

21.1 COMPANY SHARE ANALYSIS: GSA AND BENELUX

22 SWOT ANALYSIS

23 COMPANY PROFILE

23.1 F. HOFFMANN-LA ROCHE LTD

23.1.1 COMPANY SNAPSHOT

23.1.2 REVENUE ANALYSIS

23.1.3 PRODUCT PORTFOLIO

23.1.4 RECENT DEVELOPMENT

23.2 DANAHER CORPORATION

23.2.1 COMPANY SNAPSHOT

23.2.2 REVENUE ANALYSIS

23.2.3 PRODUCT PORTFOLIO

23.2.4 RECENT DEVELOPMENT

23.3 SIEMENS HEALTHINEERS AG

23.3.1 COMPANY SNAPSHOT

23.3.2 REVENUE ANALYSIS

23.3.3 PRODUCT PORTFOLIO

23.3.4 RECENT DEVELOPMENT

23.4 BIO- RAD LABORATORIES, INC.

23.4.1 COMPANY SNAPSHOT

23.4.2 REVENUE ANALYSIS

23.4.3 PRODUCT PORTFOLIO

23.4.4 RECENT DEVELOPMENT

23.5 BIOMERIEUX

23.5.1 COMPANY SNAPSHOT

23.5.2 REVENUE ANALYSIS

23.5.3 PRODUCT PORTFOLIO

23.5.4 RECENT DEVELOPMENT

23.6 ACCUBIOTECH CO., LTD.

23.6.1 COMPANY SNAPSHOT

23.6.2 PRODUCT PORTFOLIO

23.6.3 RECENT DEVELOPMENT

23.7 ABBOTT

23.7.1 COMPANY SNAPSHOT

23.7.2 REVENUE ANALYSIS

23.7.3 PRODUCT PORTFOLIO

23.7.4 RECENT DEVELOPMENT/NEWS

23.8 BINX HEALTH

23.8.1 COMPANY SNAPSHOT

23.8.2 SOLUTION PORTFOLIO

23.8.3 RECENT DEVELOPMENT

23.9 BD

23.9.1 COMPANY SNAPSHOT

23.9.2 REVENUE ANALYSIS

23.9.3 PRODUCT PORTFOLIO

23.9.4 RECENT DEVELOPMENT/NEWS

23.1 EKF DIAGNOSTICS HOLDINGS PLC

23.10.1 COMPANY SNAPSHOT

23.10.2 REVENUE ANALYSIS

23.10.3 PRODUCT PORTFOLIO

23.10.4 RECENT DEVELOPMENT

23.11 HOLOGIC, INC

23.11.1 COMPANY SNAPSHOT

23.11.2 REVENUE ANALYSIS

23.11.3 PRODUCT PORTFOLIO

23.11.4 RECENT DEVELOPMENT

23.12 MERIDIAN BIOSCIENCE, INC.

23.12.1 COMPANY SNAPSHOT

23.12.2 PRODUCT PORTFOLIO

23.12.3 RECENT DEVELOPMENT/NEWS

23.13 QIAGEN

23.13.1 COMPANY SNAPSHOT

23.13.2 REVENUE ANALYSIS

23.13.3 PRODUCT PORTFOLIO

23.13.4 RECENT DEVELOPMENT

23.14 QUIDELORTHO CORPORATION

23.14.1 COMPANY SNAPSHOT

23.14.2 REVENUE ANALYSIS

23.14.3 PRODUCT PORTFOLIO

23.14.4 RECENT DEVELOPMENT

23.15 SEKISUI DIAGNOSTICS

23.15.1 COMPANY SNAPSHOT

23.15.2 PRODUCT PORTFOLIO

23.15.3 RECENT DEVELOPMENT

23.16 SYSMEX CORPORATION

23.16.1 COMPANY SNAPSHOT

23.16.2 REVENUE ANALYSIS

23.16.3 PRODUCT PORTFOLIO

23.16.4 RECENT DEVELOPMENT

23.17 SIENCO, INC.

23.17.1 COMPANY SNAPSHOT

23.17.2 PRODUCT PORTFOLIO

23.17.3 RECENT DEVELOPMENT

23.18 TRINITY BIOTECH

23.18.1 COMPANY SNAPSHOT

23.18.2 REVENUE ANALYSIS

23.18.3 PRODUCT PORTFOLIO

23.18.4 RECENT DEVELOPMENT

23.19 THERMO FISHER SCIENTIFIC INC.

23.19.1 COMPANY SNAPSHOT

23.19.2 REVENUE ANALYSIS

23.19.3 PRODUCT PORTFOLIO

23.19.4 RECENT DEVELOPMENT

23.2 WERFEN

23.20.1 COMPANY SNAPSHOT

23.20.2 PRODUCT PORTFOLIO

23.20.3 RECENT DEVELOPMENT

24 QUESTIONNAIRE

Lista de Tabela

TABLE 1 HOME-USE POCT DEVICES WITH TELEMEDICINE INTEGRATION

TABLE 2 COMPANIES AND PRODUCTS WITH TELEMEDICINE INTEGRATION

TABLE 3 A TECHNOLOGY ROADMAP OUTLINING THE FUTURE OF CONNECTED POCT DEVICES

TABLE 4 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 5 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 6 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 7 GSA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 8 GSA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 9 GSA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 10 GSA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 11 GSA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 12 GSA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 13 GSA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 14 GSA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 15 GSA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 16 GSA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 17 GSA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 18 GSA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 19 GSA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 20 GSA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 21 GSA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 22 GSA INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 23 GSA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 24 GSA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 25 GSA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 26 GSA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 27 GSA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 28 GSA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 29 GSA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 30 GSA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 31 GSA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 32 GSA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 33 GSA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 34 GSA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 35 GSA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 36 GSA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 37 GSA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 38 GSA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 39 GSA BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 40 GSA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 41 GSA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 42 GSA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 43 GSA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 44 GSA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 45 GSA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 46 GSA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 47 GSA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 48 GSA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 49 GSA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 50 GSA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 51 GSA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 52 GSA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 53 GSA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 54 GSA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 55 GSA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 56 GSA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 57 GSA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 58 GSA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 59 GSA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 60 GSA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 61 GSA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 62 GSA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 63 GSA VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 64 GSA DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 65 GSA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 66 GSA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNIT)

TABLE 67 GSA DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 68 GSA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 69 GSA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 70 GSA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 71 GSA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 72 GSA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 73 GSA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 74 GSA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 75 GSA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 76 GSA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 77 GSA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 78 GSA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 79 GSA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 80 GSA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 81 GSA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 82 GSA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 83 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 84 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 85 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 86 GSA INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 87 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 88 GSA HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 89 GSA PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 90 GSA PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 91 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 92 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 93 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 94 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 95 BENELUX GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 96 BENELUX GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 97 BENELUX GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 98 BENELUX INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 99 BENELUX INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 100 BENELUX INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 101 BENELUX HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 102 BENELUX HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 103 BENELUX HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 104 BENELUX SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 105 BENELUX SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 106 BENELUX SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 107 BENELUX HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 108 BENELUX HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 109 BENELUX HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 110 BENELUX INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 111 BENELUX TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 112 BENELUX TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 113 BENELUX TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 114 BENELUX MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 115 BENELUX MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 116 BENELUX MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 117 BENELUX CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 118 BENELUX POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 119 BENELUX POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 120 BENELUX CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 121 BENELUX CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 122 BENELUX CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 123 BENELUX BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 124 BENELUX BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 125 BENELUX BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 126 BENELUX BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 127 BENELUX BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 128 BENELUX PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 129 BENELUX PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 130 BENELUX PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 131 BENELUX BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 132 BENELUX BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 133 BENELUX BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 134 BENELUX HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 135 BENELUX HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 136 BENELUX HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 137 BENELUX ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 138 BENELUX ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 139 BENELUX ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 140 BENELUX PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 141 BENELUX PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 142 BENELUX PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 143 BENELUX PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 144 BENELUX FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 145 BENELUX FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 146 BENELUX FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 147 BENELUX COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 148 BENELUX ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 149 BENELUX ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 150 BENELUX ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 151 BENELUX VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 152 BENELUX DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 153 BENELUX DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 154 BENELUX DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNIT)

TABLE 155 BENELUX DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 156 BENELUX RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 157 BENELUX RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 158 BENELUX RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 159 BENELUX URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 160 BENELUX URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 161 BENELUX URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 162 BENELUX CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 163 BENELUX CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 164 BENELUX CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 165 BENELUX INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 166 BENELUX INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 167 BENELUX INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 168 BENELUX FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 169 BENELUX FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 170 BENELUX FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 171 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 172 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 173 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 174 BENELUX INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 175 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 176 BENELUX HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 177 BENELUX PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 178 BENELUX PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 179 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 180 GSA & BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 181 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 182 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 183 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 184 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 185 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 186 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 187 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 188 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 189 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 190 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 191 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 192 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 193 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 194 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 195 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 196 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 197 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 198 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 199 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 200 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 201 GERMANY INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 202 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 203 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 204 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 205 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 206 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 207 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 208 GERMANY CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 209 GERMANY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 210 GERMANY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 211 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 212 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 213 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 214 GERMANY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 215 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 216 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 217 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 218 GERMANY BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 219 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 220 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 221 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 222 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 223 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 224 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 225 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 226 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 227 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 228 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 229 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 230 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 231 GERMANY PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 232 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 233 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 234 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 235 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 236 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 237 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 238 GERMANY COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 239 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 240 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 241 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 242 GERMANY VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 243 GERMANY DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 244 GERMANY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 245 GERMANY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 246 GERMANY DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 247 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 248 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 249 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 250 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 251 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 252 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 253 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 254 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 255 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 256 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 257 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 258 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 259 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 260 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 261 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 262 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 263 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 264 GERMANY INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 265 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 266 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 267 GERMANY HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 268 GERMANY PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 269 GERMANY PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 270 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 271 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 272 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 273 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 274 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 275 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 276 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 277 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 278 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 279 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 280 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 281 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 282 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 283 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 284 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 285 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 286 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 287 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 288 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 289 NETHERLANDS INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 290 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 291 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 292 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 293 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 294 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 295 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 296 NETHERLANDS CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 297 NETHERLANDS POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 298 NETHERLANDS POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 299 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 300 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 301 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 302 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 303 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 304 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 305 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 306 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 307 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 308 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 309 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 310 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 311 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 312 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 313 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 314 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 315 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 316 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 317 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 318 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 319 NETHERLANDS PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 320 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 321 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 322 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 323 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 324 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 325 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 326 NETHERLANDS COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 327 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 328 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 329 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 330 NETHERLANDS VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 331 NETHERLANDS DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 332 NETHERLANDS DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 333 NETHERLANDS DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 334 NETHERLANDS DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 335 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 336 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 337 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 338 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 339 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 340 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 341 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 342 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 343 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 344 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 345 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 346 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 347 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 348 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 349 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 350 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 351 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 352 NETHERLANDS INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 353 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 354 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 355 NETHERLANDS HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 356 NETHERLANDS PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 357 NETHERLANDS PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 358 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 359 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 360 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 361 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 362 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 363 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 364 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 365 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 366 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 367 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 368 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 369 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 370 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 371 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 372 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 373 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 374 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 375 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 376 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 377 SWITZERLAND INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 378 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 379 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 380 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 381 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 382 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 383 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 384 SWITZERLAND CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 385 SWITZERLAND POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 386 SWITZERLAND POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 387 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 388 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 389 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 390 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 391 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 392 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 393 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 394 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 395 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 396 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 397 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 398 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 399 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 400 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 401 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 402 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 403 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 404 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 405 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 406 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 407 SWITZERLAND PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 408 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 409 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 410 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 411 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 412 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 413 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 414 SWITZERLAND COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 415 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 416 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 417 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 418 SWITZERLAND VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 419 SWITZERLAND DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 420 SWITZERLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 421 SWITZERLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 422 SWITZERLAND DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 423 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 424 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 425 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 426 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 427 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 428 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 429 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 430 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 431 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 432 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 433 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 434 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 435 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 436 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 437 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 438 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 439 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 440 SWITZERLAND INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 441 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 442 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 443 SWITZERLAND HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 444 SWITZERLAND PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 445 SWITZERLAND PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 446 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 447 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 448 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 449 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 450 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 451 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 452 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 453 BELGIUM INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 454 BELGIUM INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 455 BELGIUM INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 456 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 457 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 458 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 459 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 460 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 461 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 462 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 463 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 464 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 465 BELGIUM INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 466 BELGIUM TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 467 BELGIUM TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 468 BELGIUM TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 469 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 470 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 471 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 472 BELGIUM CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 473 BELGIUM POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 474 BELGIUM POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 475 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 476 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 477 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 478 BELGIUM BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 479 BELGIUM BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 480 BELGIUM BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 481 BELGIUM BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 482 BELGIUM BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 483 BELGIUM PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 484 BELGIUM PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 485 BELGIUM PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 486 BELGIUM BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 487 BELGIUM BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 488 BELGIUM BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 489 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 490 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 491 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 492 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 493 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 494 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 495 BELGIUM PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 496 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 497 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 498 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 499 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 500 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 501 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 502 BELGIUM COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 503 BELGIUM ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 504 BELGIUM ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 505 BELGIUM ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 506 BELGIUM VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 507 BELGIUM DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 508 BELGIUM DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 509 BELGIUM DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 510 BELGIUM DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 511 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 512 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 513 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 514 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 515 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 516 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 517 BELGIUM CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 518 BELGIUM CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 519 BELGIUM CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 520 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 521 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 522 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 523 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 524 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 525 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 526 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 527 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 528 BELGIUM INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 529 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 530 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 531 BELGIUM HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 532 BELGIUM PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 533 BELGIUM PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 534 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 535 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 536 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 537 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 538 AUSTRIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 539 AUSTRIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 540 AUSTRIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 541 AUSTRIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 542 AUSTRIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 543 AUSTRIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 544 AUSTRIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 545 AUSTRIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 546 AUSTRIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 547 AUSTRIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 548 AUSTRIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 549 AUSTRIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 550 AUSTRIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 551 AUSTRIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 552 AUSTRIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 553 AUSTRIA INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 554 AUSTRIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 555 AUSTRIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 556 AUSTRIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 557 AUSTRIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 558 AUSTRIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 559 AUSTRIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 560 AUSTRIA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 561 AUSTRIA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 562 AUSTRIA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 563 AUSTRIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 564 AUSTRIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 565 AUSTRIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 566 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 567 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 568 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 569 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 570 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 571 AUSTRIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 572 AUSTRIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 573 AUSTRIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 574 AUSTRIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 575 AUSTRIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 576 AUSTRIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 577 AUSTRIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 578 AUSTRIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 579 AUSTRIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 580 AUSTRIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 581 AUSTRIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 582 AUSTRIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 583 AUSTRIA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 584 AUSTRIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 585 AUSTRIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 586 AUSTRIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 587 AUSTRIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 588 AUSTRIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 589 AUSTRIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 590 AUSTRIA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 591 AUSTRIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 592 AUSTRIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 593 AUSTRIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 594 AUSTRIA VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 595 AUSTRIA DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 596 AUSTRIA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 597 AUSTRIA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 598 AUSTRIA DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 599 AUSTRIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 600 AUSTRIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 601 AUSTRIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 602 AUSTRIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 603 AUSTRIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 604 AUSTRIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 605 AUSTRIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 606 AUSTRIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 607 AUSTRIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 608 AUSTRIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 609 AUSTRIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 610 AUSTRIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 611 AUSTRIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 612 AUSTRIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 613 AUSTRIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 614 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 615 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 616 AUSTRIA INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 617 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 618 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 619 AUSTRIA HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 620 AUSTRIA PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 621 AUSTRIA PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 622 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 623 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 624 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 625 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 626 LUXEMBOURG GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 627 LUXEMBOURG GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 628 LUXEMBOURG GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 629 LUXEMBOURG INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 630 LUXEMBOURG INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 631 LUXEMBOURG INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 632 LUXEMBOURG HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 633 LUXEMBOURG HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 634 LUXEMBOURG HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 635 LUXEMBOURG SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 636 LUXEMBOURG SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 637 LUXEMBOURG SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 638 LUXEMBOURG HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 639 LUXEMBOURG HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 640 LUXEMBOURG HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 641 LUXEMBOURG INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 642 LUXEMBOURG TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 643 LUXEMBOURG TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 644 LUXEMBOURG TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 645 LUXEMBOURG MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 646 LUXEMBOURG MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 647 LUXEMBOURG MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 648 LUXEMBOURG CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 649 LUXEMBOURG POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 650 LUXEMBOURG POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 651 LUXEMBOURG CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 652 LUXEMBOURG CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 653 LUXEMBOURG CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 654 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 655 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 656 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 657 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 658 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 659 LUXEMBOURG PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 660 LUXEMBOURG PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 661 LUXEMBOURG PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 662 LUXEMBOURG BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 663 LUXEMBOURG BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 664 LUXEMBOURG BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 665 LUXEMBOURG HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 666 LUXEMBOURG HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 667 LUXEMBOURG HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 668 LUXEMBOURG ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 669 LUXEMBOURG ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 670 LUXEMBOURG ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 671 LUXEMBOURG PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 672 LUXEMBOURG PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 673 LUXEMBOURG PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 674 LUXEMBOURG PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 675 LUXEMBOURG FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 676 LUXEMBOURG FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 677 LUXEMBOURG FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 678 LUXEMBOURG COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 679 LUXEMBOURG ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 680 LUXEMBOURG ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 681 LUXEMBOURG ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 682 LUXEMBOURG VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 683 LUXEMBOURG DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 684 LUXEMBOURG DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 685 LUXEMBOURG DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 686 LUXEMBOURG DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 687 LUXEMBOURG RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 688 LUXEMBOURG RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 689 LUXEMBOURG RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 690 LUXEMBOURG URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 691 LUXEMBOURG URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 692 LUXEMBOURG URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 693 LUXEMBOURG CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 694 LUXEMBOURG CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 695 LUXEMBOURG CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 696 LUXEMBOURG INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 697 LUXEMBOURG INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 698 LUXEMBOURG INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 699 LUXEMBOURG FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 700 LUXEMBOURG FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 701 LUXEMBOURG FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 702 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)

TABLE 703 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 704 LUXEMBOURG INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 705 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)

TABLE 706 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 707 LUXEMBOURG HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 708 LUXEMBOURG PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 709 LUXEMBOURG PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 710 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

Lista de Figura

FIGURE 1 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: SEGMENTATION

FIGURE 2 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: DATA TRIANGULATION

FIGURE 3 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: DROC ANALYSIS

FIGURE 4 GSA POINT-OF-CARE-TESTING (POCT) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 6 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 7 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: MARKET END USER COVERAGE GRID

FIGURE 10 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: SEGMENTATION

FIGURE 11 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE (2024)

FIGURE 12 BEMELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE (2024)

FIGURE 13 GSA POINT-OF-CARE-TESTING (POCT) MARKET: EXECUTIVE SUMMARY

FIGURE 14 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: EXECUTIVE SUMMARY

FIGURE 15 STRATEGIC DECISIONS

FIGURE 16 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES IS EXPECTED TO DRIVE THE GSA POINT-OF-CARE-TESTING (POCT) MARKET, IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 17 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES IS EXPECTED TO DRIVE THE BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 18 GLUCOSE MONITORING PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GSA POINT-OF-CARE-TESTING (POCT) MARKET IN THE FORECAST PERIOD OF 2025 & 2032

FIGURE 19 GLUCOSE MONITORING PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BENELUX POINT-OF-CARE-TESTING (POCT) MARKET IN THE FORECAST PERIOD OF 2025 & 2032

FIGURE 20 DROC ANALYSIS

FIGURE 21 NUMBER OF PEOPLE USING VARIOUS SUBSTANCES OR EXPERIENCING PROBLEMATIC USE PREVALENCE (PERCENTAGE)

FIGURE 22 NUMBER OF PEOPLE USING VARIOUS SUBSTANCES OR EXPERIENCING PROBLEMATIC USE (IN MILLION)

FIGURE 23 SUBSTANCE USE BEHAVIOURS AMONG 15-YEAR-OLDS IN 2022 (SELF-REPORTED PREVALENCE)

FIGURE 24 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2024

FIGURE 25 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2025-2032 (USD THOUSAND)

FIGURE 26 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, CAGR (2025-2032)

FIGURE 27 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 28 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2024

FIGURE 29 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2025 TO 2032 (USD THOUSAND)

FIGURE 30 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, CAGR (2025- 2032)

FIGURE 31 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, LIFELINE CURVE

FIGURE 32 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2024

FIGURE 33 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2025 TO 2032 (USD THOUSAND)

FIGURE 34 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, CAGR (2025- 2032)

FIGURE 35 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, LIFELINE CURVE

FIGURE 36 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2024

FIGURE 37 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)

FIGURE 38 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, CAGR (2025- 2032)..

FIGURE 39 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 40 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2024

FIGURE 41 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)

FIGURE 42 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, CAGR (2025- 2032)

FIGURE 43 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, LIFELINE CURVE

FIGURE 44 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 45 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)

FIGURE 46 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025- 2032)

FIGURE 47 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 48 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2024

FIGURE 49 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2025-2032 (USD THOUSAND)

FIGURE 50 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, CAGR (2025-2032)

FIGURE 51 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 52 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2024

FIGURE 53 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2025 TO 2032 (USD THOUSAND)

FIGURE 54 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, CAGR (2025- 2032)

FIGURE 55 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, LIFELINE CURVE

FIGURE 56 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2024

FIGURE 57 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2025 TO 2032 (USD THOUSAND)

FIGURE 58 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, CAGR (2025- 2032)

FIGURE 59 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, LIFELINE CURVE

FIGURE 60 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2024

FIGURE 61 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)

FIGURE 62 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, CAGR (2025- 2032)

FIGURE 63 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 64 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2024

FIGURE 65 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)

FIGURE 66 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, CAGR (2025- 2032)

FIGURE 67 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, LIFELINE CURVE

FIGURE 68 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 69 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)

FIGURE 70 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025- 2032)

FIGURE 71 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 72 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: SNAPSHOT (2024)

FIGURE 73 GSA POINT-OF-CARE-TESTING (POCT) MARKET: SNAPSHOT (2024)

FIGURE 74 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY SHARE 2024 (%)

View Detailed Information

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

Quais são os principais segmentos abordados no relatório Relatório de Análise de Tamanho, Participação e Tendências do Mercado?

O mercado é segmentado com base em Mercado de testes no local de atendimento (POCT) da GSA e Benelux, por tipo de produto (produtos de monitoramento de glicose, produtos de teste de doenças infecciosas, produtos de monitoramento cardiometabólico, produtos de teste de gravidez e fertilidade, produtos de teste de hematologia, produtos de monitoramento de coagulação, produtos de teste de drogas de abuso (DOA), produtos de teste de urinálise, produtos de teste de colesterol, produtos de teste de marcadores tumorais/câncer, produtos de teste de ocultismo fecal e outros), por plataforma (ensaios de fluxo lateral/testes de imunocromatografia, imunoensaios, tiras reagentes, diagnóstico molecular, ensaios de química clínica, microfluídica, hematologia, outros), por aplicação (glicose no sangue, doenças infecciosas, monitoramento de sinais vitais, monitoramento cardíaco, coagulação, hematologia, monitoramento de SpO2 não invasivo, transfusão de sangue, monitoramento de PCO2 não invasivo, sangue total Análise, Outros), Por Modo de Prescrição (Testes Baseados em Prescrição e Testes de Venda Livre), Por Usuário Final (Hospitais, Assistência Domiciliar, Clínicas, Laboratórios, Centros de Diagnóstico, Laboratórios de Patologia, Centros de Cirurgia Ambulatorial, Centros de Atendimento a Idosos, Outros), Por Canal de Distribuição (Licitação Direta, Vendas no Varejo, Vendas Online e Outros) - Tendências e Previsão do Setor até 2032 .

Qual é o tamanho atual do mercado de Relatório de Análise de Tamanho, Participação e Tendências do Mercado?

O tamanho do Relatório de Análise de Tamanho, Participação e Tendências do Mercado foi avaliado em USD 3.63 USD Billion no ano de 2024.

Qual é a taxa de crescimento esperada para Relatório de Análise de Tamanho, Participação e Tendências do Mercado?

O Relatório de Análise de Tamanho, Participação e Tendências do Mercado está projetado para crescer a um CAGR de 12.1% durante o período de previsão de 2025 a 2032.

Quem são os principais players do Relatório de Análise de Tamanho, Participação e Tendências do Mercado?

Os principais players do mercado incluem F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthineers AG, Bio-Rad Laboratories Inc., BIOMÉRIEUX.

Relatório de Análise de Tamanho, Participação e Tendências do Mercado de Testes no Ponto de Atendimento (POCT) da GSA e Benelux – Visão Geral do Setor e Previsão até 2032

Contorne os desafios das tarifas com uma consultoria ágil da cadeia de abastecimento

Gsa And Benelux Point Care Testing Poct Market

CAGR : 12.10 %

Tamanho do mercado de testes no ponto de atendimento (POCT)

Análise de mercado de testes no ponto de atendimento (POCT)

Escopo de mercado de testes no ponto de atendimento (POCT)

“A Alemanha detém a maior fatia do mercado de testes no local de atendimento (POCT)”

“Prevê-se que a Holanda registre o maior CAGR no mercado de testes no ponto de atendimento (POCT)”

Participação de mercado de testes no ponto de atendimento (POCT)

Últimos desenvolvimentos no mercado de testes no ponto de atendimento (POCT) da GSA e Benelux

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

Índice

Lista de Tabela

Lista de Figura

Metodologia de Investigação

Personalização disponível

Perguntas frequentes

ISO Certifications

Relatórios

Informações de mercado

Apoiar

Soluções

Relatório de Análise de Tamanho, Participação e Tendências do Mercado de Testes no Ponto de Atendimento (POCT) da GSA e Benelux – Visão Geral do Setor e Previsão até 2032

Contorne os desafios das tarifas com uma consultoria ágil da cadeia de abastecimento

Gsa And Benelux Point Care Testing Poct Market

CAGR : 12.10 %

Tamanho do mercado de testes no ponto de atendimento (POCT)

Análise de mercado de testes no ponto de atendimento (POCT)

Escopo de mercado de testes no ponto de atendimento (POCT)

“A Alemanha detém a maior fatia do mercado de testes no local de atendimento (POCT)”

“Prevê-se que a Holanda registre o maior CAGR no mercado de testes no ponto de atendimento (POCT)”

Participação de mercado de testes no ponto de atendimento (POCT)

Últimos desenvolvimentos no mercado de testes no ponto de atendimento (POCT) da GSA e Benelux

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

Índice

Lista de Tabela

Lista de Figura

Metodologia de Investigação

Personalização disponível

Perguntas frequentes

Navegue pelas páginas relacionadas